Showing results (461-470 of 473) with videos related to

Sort By:
Pageof 48
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
JAMA Neurology|June 18, 2023
Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical TrialStefan Wolf, Dorothee Mielke, Christoph Barner, et al.
Der Anaesthesist|June 28, 2008
[Study protocol of the VISEP study. Response of the SepNet study group]K Reinhart, F M Brunkhorst, C Engel, et al.
JAMA Psychiatry|October 15, 2025
Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder: A Randomized Clinical TrialJohn C Fortney, Debra L Kaysen, Charles C Engel, et al.
British Journal of Cancer|September 11, 2008
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriersA Osorio, M Pollán, G Pita, et al.
Gut|January 16, 2008
Guidelines for the clinical management of familial adenomatous polyposis (FAP)H F A Vasen, G Möslein, A Alonso, et al.
Familial Cancer|September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
JAMA|March 15, 2003
Cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: a randomized controlled trialSam T Donta, Daniel J Clauw, Charles C Engel, et al.
Blood|September 13, 2012
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plansFabio Candotti, Kit L Shaw, Linda Muul, et al.
Pageof 48